|
|
|
mRNA EVENT SERIES: THE FUTURE OF mRNA MANUFACTURING
|
|
|
|
|
|
|
Join us at a two-day event on October 8th and 9th focused on the future of mRNA manufacturing, where we will be presenting the latest industry trends and addressing technical challenges. We will showcase our end-to-end solution for mRNA manufacturing, the Cytiva FlexFactory™ process train in a KUBio™ box trailer, built in association with mobile solutions provider Germfree Laboratories. Click here to register.
|
|
|
|
|
|
|
The need for automated and digital mRNA manufacturing platforms is growing rapidly as their use for mRNA-based therapeutics and for precision medicines continues to rise. One of the biggest challenges in bringing these life-changing therapies to patients is the ability to efficiently produce a range of batch sizes while maintaining necessary flexibility, reduced costs, and speed to market. Learn more about a paperless manufacturing solution in the Cytiva FlexFactory™ biomanufacturing process train with Chronicle™ automation software.
|
|
|
|
|
The Cytiva FlexFactory process train was designed to be used for multiple modalities, including mRNA, and from lab scale to production scale. In this infographic, learn more about how the FlexFactory platform addresses five key pain points: flexible scalability, time risk, training, digital maturity, and compliance qualification. Cytiva can help mRNA manufacturers scale flexibly while increasing their site's digital maturity.
|
|
|
|
|
Successful production of mRNA-based COVID-19 vaccines has both helped prove the efficacy and safety of this new modality as well as catalyzed interest and investment in developing RNA therapeutics for treating cancer, rare diseases, and more. Cytiva offers an end-to-end solution for mRNA manufacturing, including lipid nanoparticle (LNP) formulation. Read more about key stages in mRNA–LNP development, and consider how the Cytiva FlexFactory process train inside a KUBio™ modular environment, KUBio box, or KUBio trailer can meet evolving needs.
|
|
|
|
|
|
|
The Cytiva KUBio box solution offers flexibility and scalability for all your mRNA workflows, from lab scale to production scale. It is designed to increase speed to market and reduce footprint with investment and timeline defined up-front, from project start through facility and equipment qualification, including on-site training. The KUBio modular facility comes equipped with a FlexFactory process train inside — helping enable the future of mRNA manufacturing. Come see what’s inside the box. Watch the video.
|
|
|
|
|
FlexFactory™ Platform in KUBio™ Modular Environment: A Flexible, Scalable, Integrated Solution for mRNA Manufacturing
For mRNA manufacturers, flexibility, reduced costs, and speed to market are critical considerations. Learn more about the Cytiva products and services that can help you throughout your mRNA manufacturing journey — from development and manufacture, right through to the regulatory approval of mRNA-based therapies.
|
|
• Request Information
|
|
|
|
|
|
|
|
